PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data Transcript By Delta Glacier · March 31, 2026 · 1 min read pepgsa transcripts Source: seekingalpha.com